Public Joint-Stock Company "Human Stem Cells Institute" Reports Earnings Results for the Full Year Ended December 31, 2021
May 05, 2022 at 08:04 am EDT
Public Joint-Stock Company "Human Stem Cells Institute" reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was RUB 1,180.79 million compared to RUB 1,084.02 million a year ago. Net income was RUB 11.63 million compared to RUB 72.85 million a year ago. Basic earnings per share from continuing operations was RUB 0.15 compared to RUB 0.97 a year ago. Diluted earnings per share from continuing operations was RUB 0.15 compared to RUB 0.97 a year ago.